Selected research
Industry Research
Below-Knee Anti-Embolism Socks Industry Research Report 2026
Market perspective
The global Below-Knee Anti-Embolism Socks market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Below-Knee Anti-Embolism Socks is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Below-Knee Anti-Embolism Socks is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Below-Knee Anti-Embolism Socks is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Below-Knee Anti-Embolism Socks include Varitek, Medtronic(Covidien), Sigvaris, Medi, BSN Medical, Juzo, 3M, Bauerfeind AG and Thuasne Corporate, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Below-Knee Anti-Embolism Socks market in terms of revenue (US$ million) and, where applicable, sales volume (k pairs), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k pairs) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Below-Knee Anti-Embolism Socks Market by Company
Varitek
Medtronic(Covidien)
Sigvaris
Medi
BSN Medical
Juzo
3M
Bauerfeind AG
Thuasne Corporate
Pretty Legs Hosiery
Salzmann-Group
Paul Hartmann
Cizeta Medicali
Belsana Medical
Gloria Med
Zhende Medical Group
Maizi
TOKO
Okamoto Corporation
Below-Knee Anti-Embolism Socks Segment by Type
Open Toes
Closed Toes
Below-Knee Anti-Embolism Socks Segment by Application
Online Sales
Offline Sales
Below-Knee Anti-Embolism Socks Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Below-Knee Anti-Embolism Socks market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Below-Knee Anti-Embolism Socks and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Below-Knee Anti-Embolism Socks.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Below-Knee Anti-Embolism Socks manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Below-Knee Anti-Embolism Socks by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Below-Knee Anti-Embolism Socks in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Open Toes
- Closed Toes
Applications
- Online Sales
- Offline Sales
Companies covered
- Varitek
- Medtronic(Covidien)
- Sigvaris
- Medi
- BSN Medical
- Juzo
- 3M
- Bauerfeind AG
- Thuasne Corporate
- Pretty Legs Hosiery
- Salzmann-Group
- Paul Hartmann
- Cizeta Medicali
- Belsana Medical
- Gloria Med
- Zhende Medical Group
- Maizi
- TOKO
- Okamoto Corporation
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Below-Knee Anti-Embolism Socks Market Size (2021-2032)
- 2.2.2 Global Below-Knee Anti-Embolism Socks Sales (2021-2032)
- 2.2.3 Global Below-Knee Anti-Embolism Socks Market Average Price (2021-2032)
- 2.3 Below-Knee Anti-Embolism Socks by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Open Toes
- 2.3.3 Closed Toes
- 2.4 Below-Knee Anti-Embolism Socks by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Online Sales
- 2.4.3 Offline Sales
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Below-Knee Anti-Embolism Socks Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Below-Knee Anti-Embolism Socks Sales (k pairs) of Manufacturers (2021-2026)
- 3.3 Global Below-Knee Anti-Embolism Socks Revenue of Manufacturers (2021-2026)
- 3.4 Global Below-Knee Anti-Embolism Socks Average Price by Manufacturers (2021-2026)
- 3.5 Global Below-Knee Anti-Embolism Socks Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Below-Knee Anti-Embolism Socks, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Below-Knee Anti-Embolism Socks, Product Type & Application
- 3.8 Global Manufacturers of Below-Knee Anti-Embolism Socks, Established Date
- 3.9 Global Below-Knee Anti-Embolism Socks Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Varitek
- 4.1.1 Varitek Company Information
- 4.1.2 Varitek Business Overview
- 4.1.3 Varitek Below-Knee Anti-Embolism Socks Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Varitek Below-Knee Anti-Embolism Socks Product Portfolio
- 4.1.5 Varitek Recent Developments
- 4.2 Medtronic(Covidien)
- 4.2.1 Medtronic(Covidien) Company Information
- 4.2.2 Medtronic(Covidien) Business Overview
- 4.2.3 Medtronic(Covidien) Below-Knee Anti-Embolism Socks Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Medtronic(Covidien) Below-Knee Anti-Embolism Socks Product Portfolio
- 4.2.5 Medtronic(Covidien) Recent Developments
- 4.3 Sigvaris
- 4.3.1 Sigvaris Company Information
- 4.3.2 Sigvaris Business Overview
- 4.3.3 Sigvaris Below-Knee Anti-Embolism Socks Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Sigvaris Below-Knee Anti-Embolism Socks Product Portfolio
- 4.3.5 Sigvaris Recent Developments
- 4.4 Medi
- 4.4.1 Medi Company Information
- 4.4.2 Medi Business Overview
- 4.4.3 Medi Below-Knee Anti-Embolism Socks Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Medi Below-Knee Anti-Embolism Socks Product Portfolio
- 4.4.5 Medi Recent Developments
- 4.5 BSN Medical
- 4.5.1 BSN Medical Company Information
- 4.5.2 BSN Medical Business Overview
- 4.5.3 BSN Medical Below-Knee Anti-Embolism Socks Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 BSN Medical Below-Knee Anti-Embolism Socks Product Portfolio
- 4.5.5 BSN Medical Recent Developments
- 4.6 Juzo
- 4.6.1 Juzo Company Information
- 4.6.2 Juzo Business Overview
- 4.6.3 Juzo Below-Knee Anti-Embolism Socks Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Juzo Below-Knee Anti-Embolism Socks Product Portfolio
- 4.6.5 Juzo Recent Developments
- 4.7 3M
- 4.7.1 3M Company Information
- 4.7.2 3M Business Overview
- 4.7.3 3M Below-Knee Anti-Embolism Socks Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 3M Below-Knee Anti-Embolism Socks Product Portfolio
- 4.7.5 3M Recent Developments
- 4.8 Bauerfeind AG
- 4.8.1 Bauerfeind AG Company Information
- 4.8.2 Bauerfeind AG Business Overview
- 4.8.3 Bauerfeind AG Below-Knee Anti-Embolism Socks Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Bauerfeind AG Below-Knee Anti-Embolism Socks Product Portfolio
- 4.8.5 Bauerfeind AG Recent Developments
- 4.9 Thuasne Corporate
- 4.9.1 Thuasne Corporate Company Information
- 4.9.2 Thuasne Corporate Business Overview
- 4.9.3 Thuasne Corporate Below-Knee Anti-Embolism Socks Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Thuasne Corporate Below-Knee Anti-Embolism Socks Product Portfolio
- 4.9.5 Thuasne Corporate Recent Developments
- 4.10 Pretty Legs Hosiery
- 4.10.1 Pretty Legs Hosiery Company Information
- 4.10.2 Pretty Legs Hosiery Business Overview
- 4.10.3 Pretty Legs Hosiery Below-Knee Anti-Embolism Socks Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Pretty Legs Hosiery Below-Knee Anti-Embolism Socks Product Portfolio
- 4.10.5 Pretty Legs Hosiery Recent Developments
- 4.11 Salzmann-Group
- 4.11.1 Salzmann-Group Company Information
- 4.11.2 Salzmann-Group Business Overview
- 4.11.3 Salzmann-Group Below-Knee Anti-Embolism Socks Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Salzmann-Group Below-Knee Anti-Embolism Socks Product Portfolio
- 4.11.5 Salzmann-Group Recent Developments
- 4.12 Paul Hartmann
- 4.12.1 Paul Hartmann Company Information
- 4.12.2 Paul Hartmann Business Overview
- 4.12.3 Paul Hartmann Below-Knee Anti-Embolism Socks Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Paul Hartmann Below-Knee Anti-Embolism Socks Product Portfolio
- 4.12.5 Paul Hartmann Recent Developments
- 4.13 Cizeta Medicali
- 4.13.1 Cizeta Medicali Company Information
- 4.13.2 Cizeta Medicali Business Overview
- 4.13.3 Cizeta Medicali Below-Knee Anti-Embolism Socks Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Cizeta Medicali Below-Knee Anti-Embolism Socks Product Portfolio
- 4.13.5 Cizeta Medicali Recent Developments
- 4.14 Belsana Medical
- 4.14.1 Belsana Medical Company Information
- 4.14.2 Belsana Medical Business Overview
- 4.14.3 Belsana Medical Below-Knee Anti-Embolism Socks Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Belsana Medical Below-Knee Anti-Embolism Socks Product Portfolio
- 4.14.5 Belsana Medical Recent Developments
- 4.15 Gloria Med
- 4.15.1 Gloria Med Company Information
- 4.15.2 Gloria Med Business Overview
- 4.15.3 Gloria Med Below-Knee Anti-Embolism Socks Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Gloria Med Below-Knee Anti-Embolism Socks Product Portfolio
- 4.15.5 Gloria Med Recent Developments
- 4.16 Zhende Medical Group
- 4.16.1 Zhende Medical Group Company Information
- 4.16.2 Zhende Medical Group Business Overview
- 4.16.3 Zhende Medical Group Below-Knee Anti-Embolism Socks Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Zhende Medical Group Below-Knee Anti-Embolism Socks Product Portfolio
- 4.16.5 Zhende Medical Group Recent Developments
- 4.17 Maizi
- 4.17.1 Maizi Company Information
- 4.17.2 Maizi Business Overview
- 4.17.3 Maizi Below-Knee Anti-Embolism Socks Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 Maizi Below-Knee Anti-Embolism Socks Product Portfolio
- 4.17.5 Maizi Recent Developments
- 4.18 TOKO
- 4.18.1 TOKO Company Information
- 4.18.2 TOKO Business Overview
- 4.18.3 TOKO Below-Knee Anti-Embolism Socks Sales, Revenue and Gross Margin (2021-2026)
- 4.18.4 TOKO Below-Knee Anti-Embolism Socks Product Portfolio
- 4.18.5 TOKO Recent Developments
- 4.19 Okamoto Corporation
- 4.19.1 Okamoto Corporation Company Information
- 4.19.2 Okamoto Corporation Business Overview
- 4.19.3 Okamoto Corporation Below-Knee Anti-Embolism Socks Sales, Revenue and Gross Margin (2021-2026)
- 4.19.4 Okamoto Corporation Below-Knee Anti-Embolism Socks Product Portfolio
- 4.19.5 Okamoto Corporation Recent Developments
5 Global Below-Knee Anti-Embolism Socks Market Scenario by Region
- 5.1 Global Below-Knee Anti-Embolism Socks Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Below-Knee Anti-Embolism Socks Sales by Region: 2021-2032
- 5.2.1 Global Below-Knee Anti-Embolism Socks Sales by Region: 2021-2026
- 5.2.2 Global Below-Knee Anti-Embolism Socks Sales by Region: 2027-2032
- 5.3 Global Below-Knee Anti-Embolism Socks Revenue by Region: 2021-2032
- 5.3.1 Global Below-Knee Anti-Embolism Socks Revenue by Region: 2021-2026
- 5.3.2 Global Below-Knee Anti-Embolism Socks Revenue by Region: 2027-2032
- 5.4 North America Below-Knee Anti-Embolism Socks Market Facts & Figures by Country
- 5.4.1 North America Below-Knee Anti-Embolism Socks Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Below-Knee Anti-Embolism Socks Sales by Country (2021-2032)
- 5.4.3 North America Below-Knee Anti-Embolism Socks Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Below-Knee Anti-Embolism Socks Market Facts & Figures by Country
- 5.5.1 Europe Below-Knee Anti-Embolism Socks Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Below-Knee Anti-Embolism Socks Sales by Country (2021-2032)
- 5.5.3 Europe Below-Knee Anti-Embolism Socks Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Below-Knee Anti-Embolism Socks Market Facts & Figures by Country
- 5.6.1 Asia Pacific Below-Knee Anti-Embolism Socks Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Below-Knee Anti-Embolism Socks Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Below-Knee Anti-Embolism Socks Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Below-Knee Anti-Embolism Socks Market Facts & Figures by Country
- 5.7.1 South America Below-Knee Anti-Embolism Socks Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Below-Knee Anti-Embolism Socks Sales by Country (2021-2032)
- 5.7.3 South America Below-Knee Anti-Embolism Socks Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Below-Knee Anti-Embolism Socks Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Below-Knee Anti-Embolism Socks Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Below-Knee Anti-Embolism Socks Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Below-Knee Anti-Embolism Socks Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Below-Knee Anti-Embolism Socks Sales by Type (2021-2032)
- 6.1.1 Global Below-Knee Anti-Embolism Socks Sales by Type (2021-2032) & (k pairs)
- 6.1.2 Global Below-Knee Anti-Embolism Socks Sales Market Share by Type (2021-2032)
- 6.2 Global Below-Knee Anti-Embolism Socks Revenue by Type (2021-2032)
- 6.2.1 Global Below-Knee Anti-Embolism Socks Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Below-Knee Anti-Embolism Socks Revenue Market Share by Type (2021-2032)
- 6.3 Global Below-Knee Anti-Embolism Socks Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Below-Knee Anti-Embolism Socks Sales by Application (2021-2032)
- 7.1.1 Global Below-Knee Anti-Embolism Socks Sales by Application (2021-2032) & (k pairs)
- 7.1.2 Global Below-Knee Anti-Embolism Socks Sales Market Share by Application (2021-2032)
- 7.2 Global Below-Knee Anti-Embolism Socks Revenue by Application (2021-2032)
- 7.2.1 Global Below-Knee Anti-Embolism Socks Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Below-Knee Anti-Embolism Socks Revenue Market Share by Application (2021-2032)
- 7.3 Global Below-Knee Anti-Embolism Socks Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Below-Knee Anti-Embolism Socks Value Chain Analysis
- 8.1.1 Below-Knee Anti-Embolism Socks Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Below-Knee Anti-Embolism Socks Production Mode & Process
- 8.2 Below-Knee Anti-Embolism Socks Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Below-Knee Anti-Embolism Socks Distributors
- 8.2.3 Below-Knee Anti-Embolism Socks Customers
9 Global Below-Knee Anti-Embolism Socks Analyzing Market Dynamics
- 9.1 Below-Knee Anti-Embolism Socks Industry Trends
- 9.2 Below-Knee Anti-Embolism Socks Industry Drivers
- 9.3 Below-Knee Anti-Embolism Socks Industry Opportunities and Challenges
- 9.4 Below-Knee Anti-Embolism Socks Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst